Stock market announcement archive

April 18, 2023
Bergen, Norway 18 April 2023 The Annual General Meeting of Lifecare AS was convened as a hybrid meeting on 18 April 2023. Morten Foros Krohnstad (Chairman of the Board) and Hans Johan Hekland (Board member) was re-elected as proposed by the Nomination Committee, with no alternative candidates proposed. All proposals on the agenda were adopted, […]
Read more
April 11, 2023
Reference is made to Lifecare AS (LIFE) stock exchange notification 6 February2023.Today, Lifecare is pleased to announce that a sensor first used in our ongoingClinical Development Study has confirmed an operational longevity of 12 weeks ina continued laboratory (in vitro) set up. This is yet another importantmilestone in the development of our Sencell technology for […]
Read more
March 31, 2023
Bergen, Norway 31 March 2023The Annual General Meeting ("AGM") of Lifecare AS will be held on 18 April 2023at 10:00 CET. Notice of the AGM is enclosed to this announcement. Documents forthe AGM are available at www.lifecare.attme.dev/events/. The meeting will be conducted as a combined in-person and digital meeting.Shareholders who wish to participate and vote […]
Read more
March 31, 2023
The Clinical Development Study with the Sencell sensor will continue for a fewmore weeks. - We operate complex and pioneering sensor technology and strive to ensure highquality at all stages of the process. We therefore want to extend the ClinicalDevelopment Study by a few weeks more than previously communicated, says CEOJoacim Holter. The sensors we […]
Read more
March 28, 2023
For Lifecare 2022 was characterized by confirmation of the technology, ClinicalDevelopment Study, and building an organization that makes us even more robustand competent to face upcoming challenges. - Important milestone achievementsnaturally provide a good basis for the ongoing work related to the glucosesensor, CEO Joacim Holter states.- Our organization proved its capacity in full strength […]
Read more
March 23, 2023
Lifecare is pleased to announce that its wholly owned subsidiary LifecareLaboratory GmbH in Mainz, Germany, has been successfully audited as part of theupcoming ISO certification. "It is reassuring that our operational organizationhas passed this audit without any major findings. This is a good fundament forour continued work on regulatory processes." says CEO Joacim Holter.Lifecare's main […]
Read more
February 28, 2023
Bergen, Norway 28 February 2023Today Lifecare publish Q4 2022 interim report. The consolidated group financials show a revenue in Q4 of 5.31 MNOK, compared to1,6 MNOK in Q4 2021. The unaudited interim figures for 2022 show a revenue of20,7 MNOK compared to 1,6 MNOK in 2021. The report is attached to this releaseand are also […]
Read more
February 22, 2023
The upcoming days Lifecare will be productive and important for Lifecare in inBerlin where two presentations will be held at the prestigious conference ATTD.The company will also attend the steering committee of the FORGETDIABETESconsortium. PRESENTATIONS AT ATTD IN BERLIN In the next days, Lifecare will participate at the 16th International Conferenceon Advanced Technologies & Treatments […]
Read more
February 6, 2023
Ongoing clinical development study confirms Lifecare's expectation of a sensorlongevity that far exceeds the lifetime of existing and commercially availableneedle sensors for glucose monitoring. Today Lifecare can report that sensors used in a three-day clinical studycontinue to work in an in vitro set up, showing an operational longevity for atotal of 4 weeks and still […]
Read more
January 30, 2023
Financial calendar for Lifecare ASFINANCIAL YEAR 202228.03.2023 - Annual Report28.02.2023 - Quarterly Report - Q4FINANCIAL YEAR 202323.08.2023 - Half-yearly Report18.04.2023 - Annual General Meeting10.05.2023 - Quarterly Report - Q108.11.2023 - Quarterly Report - Q3This information is published pursuant to the requirements set out in theContinuing obligations.
Read more